Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BrightGene(688166) the Revenue is 353.16 M (+22.42%);the EBIT is 82.15 M (+276.9%);the EPS is 0.132 (+1233%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.35B22.42%
----
----
EBIT
0.08B276.92%
----
----
EPS
0.13161232.60%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf